DNMT1 and hereditary clear cell renal cell carcinoma: MG98 is a promising human DNMT1 antisense inhibitor that does not require incorporation into DNA since it downregulates DNMT1 expression and cancer cell proliferation by reducing the cellular mRNA concentration in a dose-dependent manner in renal cell carcinoma [75].